The global disposable prefilled syringes market size was valued at USD 7.3 billion in 2024 and is projected to reach USD 15.5 billion by 2030, growing at a strong compound annual growth rate (CAGR) of 13.7% from 2025 to 2030. The market growth is primarily driven by several key factors. Firstly, the increasing demand for biologic drugs which require precise, sterile, and reliable delivery systems has significantly boosted the adoption of prefilled syringes. Secondly, the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, has increased the need for long-term injectable treatments. In addition, there is a growing preference among patients and healthcare providers for self-administered injectable therapies, which prefilled syringes enable due to their convenience, accuracy, and safety.

Prefilled syringes offer multiple advantages over conventional vials and ampoules. They improve patient safety by reducing the risk of dosing errors, minimize the chances of contamination, and ensure precise dosage delivery. These benefits are key factors supporting their widespread acceptance among healthcare professionals and patients. Furthermore, advancements in syringe technologies such as the development of glass-based syringes for stability and polymer-based syringes for durability and break-resistance are further enhancing usability and expanding their scope of application. Additionally, the expansion of healthcare infrastructure in both developed and emerging economies, along with regulatory approvals for novel biologic therapies, is expected to fuel further growth in this industry.

The disposable prefilled syringes industry is moderately concentrated, with leading players such as BD (Becton, Dickinson and Company), Gerresheimer, Schott AG, and West Pharmaceutical Services holding significant market positions. These companies are heavily focused on research and innovation, particularly in areas such as syringe material improvements, advanced safety features (e.g., needle safety systems), and compatibility with a wide range of injectable drugs. The market is characterized by a combination of high demand for biologics, the increasing trend of self-administration, and the need for compliance with stringent regulatory standards across regions.

While opportunities for growth are vast, the industry also faces notable challenges. Pricing pressure from healthcare providers and governments is a significant restraint, as is the ongoing requirement to comply with evolving global regulatory frameworks. Nonetheless, leading players are investing in polymer-based syringe solutions to improve drug stability, particularly for sensitive biologics, which creates avenues for product differentiation and higher adoption rates.

Key Market Trends & Insights:

• Regional Insights: Europe emerged as the dominant regional market, accounting for a 37.4% revenue share in 2024, largely driven by strong healthcare infrastructure, high adoption of biologics, and supportive government regulations.
• By Material: The glass syringes segment accounted for the largest share at 57.4% in 2024, owing to their superior drug compatibility and widespread use in biologics. However, the plastic (polymer) syringes segment is projected to grow at the fastest CAGR during the forecast period, supported by benefits such as lower breakage risk, lightweight design, and compatibility with next-generation drugs.
• By Application: The vaccines and immunizations segment dominated with a 26.2% market share in 2024, reflecting the global push for immunization programs and routine vaccination. Meanwhile, the anaphylaxis treatment segment is anticipated to grow at the highest CAGR during the forecast period, driven by the increasing availability and use of epinephrine auto-injectors for emergency care.
• By Distribution Channel: The hospitals segment held the largest share of 57.3% in 2024, as hospitals remain the primary centers for drug administration and bulk procurement. However, online pharmacies are expected to register the fastest growth rate due to rising digital healthcare adoption, convenience, and wider access for patients opting for self-administration.

Order a free sample PDF of the Disposable Prefilled Syringes Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 7.3 Billion
• 2030 Projected Market Size: USD 15.5 Billion
• CAGR (2025-2030): 13.7%
• Europe: Largest market in 2024

Key Companies & Market Share Insights:

The competitive landscape of the disposable prefilled syringes market is intensely competitive, with both established global players and emerging companies actively participating. Prominent companies such as West Pharmaceutical Services, Medtronic, and SCHOTT Pharma AG hold strong positions due to their diversified product portfolios, technological innovations, and global distribution networks.

To strengthen their market position, these companies are adopting a combination of organic growth strategies (such as product launches, innovation in syringe materials, and technology integration) and inorganic strategies (including mergers, acquisitions, partnerships, and regional expansions). These efforts are aimed at addressing the unmet medical needs of patients, expanding into new geographies, and ensuring compliance with regulatory requirements. As the demand for biologics and self-injectable therapies continues to rise, competition among these players is expected to intensify further.

Key Players

• Becton, Dickinson and Company (BD)
• Gerresheimer AG
• SCHOTT AG
• West Pharmaceutical Services, Inc.
• Medtronic
• Roche Holding AG
• Fresenius Kabi AG
• SteriPack
• Ypsomed AG
• Meda Pharmaceuticals

Explore our latest blogs: Global Industry Herald

Conclusion:

The disposable prefilled syringes market is poised for robust growth, driven by rising demand for biologics, increasing prevalence of chronic diseases, and the growing preference for self-administered treatments. Technological advancements in syringe materials, along with improvements in safety and usability, are further enhancing product adoption. While the market faces challenges such as pricing pressures and strict regulatory compliance, expanding healthcare infrastructure and strong investments from leading players are creating new opportunities. Overall, the industry is expected to witness sustained growth as innovation, patient convenience, and global healthcare needs continue to drive demand.